Mark Carthy - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Mark Carthy made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Mark Carthy made no insider transaction in Opus Genetics Inc (IRD). Other recent insider transactions involving Opus Genetics Inc (IRD) include a net purchase of 30,000 shares made by George Magrath , and a net purchase of 2,000 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Opus Genetics Inc (IRD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opus Genetics Inc (IRD) were sold and 45,500 shares were bought by its insiders, resulting in a net purchase of 45,500 shares.

Opus Genetics Inc (IRD)'s detailed insider trading history can be found in Insider Trading Tracker table.